Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advanced lung cancer
1Servizio Oncologico Cantonale, Ospedale San Giovanni, 6500 Bellinzona, Switzerland
2Istituto Patologico Cantonale, 6600 Locarno, Switzerland
3Formed, Statistics for Medecine, 1983 Evolène, Switzerland
Received July 28, 1998; Revised November 27, 1998; Accepted December 4, 1998.
The Full Text of this article is available as a PDF
Keywords: myelotoxicity, chemotherapy, hormones, melatonin